Danske Bank’s Alterity Therapeutics ATHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4 Hold
1
– – ﹤0.01% 1092
2026
Q2
$5 Hold
1
– – ﹤0.01% 1088
2026
Q1
$4 Hold
1
– – ﹤0.01% 1112
2025
Q4
$3 Hold
1
– – ﹤0.01% 1521
2025
Q3
$4 Hold
1
– – ﹤0.01% 1443
2025
Q2
$4 Hold
1
– – ﹤0.01% 1481
2025
Q1
$3 Hold
1
– – ﹤0.01% 1332
2024
Q4
$3 Hold
1
– – ﹤0.01% 1364
2024
Q3
$1 Buy
+1
New +$1 ﹤0.01% 1583

Other funds holding ATHE

Danske Bank's ATHE Position: Q3 2026 in Review

Danske Bank held its Alterity Therapeutics (ATHE) position steady in Q3 2026 at 1 share worth $4. The position accounts for ﹤0.01% of the portfolio, ranked #1092.

Danske Bank first reported a position in ATHE in Q3 2024 and has held it in 9 quarters since. The position peaked at $5 in Q2 2026. 22 funds tracked by Wall St. Rank hold ATHE as of Q3 2026.

  • Danske Bank held 1 share of Alterity Therapeutics worth $4 as of Q3 2026.
  • Danske Bank left its Alterity Therapeutics share count unchanged in Q3 2026.
  • Alterity Therapeutics made up ﹤0.01% of Danske Bank's portfolio in Q3 2026, its #1092 holding.
  • Danske Bank first reported a position in Alterity Therapeutics in Q3 2024 and has held it in 9 quarters since.
  • Danske Bank's Alterity Therapeutics position peaked at $5 in Q2 2026.
  • 22 funds tracked by Wall St. Rank held Alterity Therapeutics as of Q3 2026.

Based on Danske Bank's 13F filing for Q3 2026, filed 9 Nov 2026.